Researchers at Mount Sinai and Memorial Sloan Kettering believe they’ve made a breakthrough in a new form of cancer treatment ...

Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ...

A collaborative effort between Mount Sinai and Memorial Sloan Kettering Cancer Center has shed valuable light on how ...

In an intriguing revelation from recent research, mitochondria have been shown not only to power the cell but also to ...

An expanding body of research indicates that aerobic exercise and strength-training can improve the chances of survival.

Researchers at The Tisch Cancer Institute at Mount Sinai, in collaboration with Memorial Sloan Kettering Cancer Center (MSK), ...

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will ...

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors - a type of immunotherapy - ...

Testing BRCA2 has long been a staple of hereditary cancer testing, as pathogenic variants in the gene are associated with cancers of the breast, ovary, prostate, and pancreas. 2-5 Despite the ...